Stock Events

Alpa Laboratories 

₹101.7
2
+₹0+0% Today

Statistics

Day High
105
Day Low
97.5
52W High
106.6
52W Low
50.3
Volume
871,381
Avg. Volume
218,044
Mkt Cap
1.31B
P/E Ratio
27.51
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12FebExpected
Q4 2017
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Next
-1.33
-0.52
0.28
1.09
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ALPA.NSE. It's not an investment recommendation.

About

Alpa Laboratories Limited engages in manufacturing and selling pharmaceutical finished dosage forms in India. It offers ethical, generic, and over the counter products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, ointments, creams, and gels for human use. The company also provides boluses, injections, and intra-mammary infusions for veterinary use. In addition, the company provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations. It sells its products through distributors, retail chemists, retail pharmacy stores, and hospitals. The company also exports its products to South and Central America, Africa, and Asia, and CIS countries. Alpa Laboratories Limited was founded in 1967 and is based in Indore, India.
Show more...
CEO
Mr. Mahendra Singh Chawla
Employees
393
Country
IN
ISIN
INE385I01010

Listings